A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck

Trial Profile

A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 05 Aug 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Mucositis; Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
    • 12 Apr 2016 Treatment arms changed from 2 to 1.
    • 12 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top